4D-ICE + TEE Imaging for Atrial Fibrillation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to guide a procedure called Left Atrial Appendage Closure (LAAC), which helps prevent strokes in individuals with atrial fibrillation, a heart rhythm disorder. The trial compares two imaging techniques: 4D Intracardiac Echocardiography (4D-ICE) and Transesophageal Echocardiography (TEE), to determine which provides better guidance during the procedure. Participants may qualify if they have experienced atrial fibrillation and plan to undergo LAAC using an Amplatzer Amulet or WATCHMAN FLX device. As an unphased trial, this study allows participants to contribute to innovative research that could enhance future stroke prevention methods.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this imaging technique is safe for atrial fibrillation procedures?
Previous studies found 4D Intracardiac Echocardiography (ICE) to be safe. Various heart procedures used it, and patients handled it well, with no major issues reported.
In contrast, Transesophageal Echocardiography (TEE) has a mixed safety record. Although usually safe, serious problems have occurred in about 5.3% to 6.1% of cases during heart procedures.
Both 4D ICE and TEE have specific safety considerations. While 4D ICE seems to cause fewer problems, TEE remains widely used and trusted, despite some risks.12345Why are researchers excited about this trial?
Researchers are excited about the 4D-ICE + TEE imaging techniques for atrial fibrillation because these methods could enhance the precision and safety of left atrial appendage closure. Traditional approaches often rely on transesophageal echocardiography (TEE) alone for imaging, but this trial explores using 4D intracardiac echocardiography (ICE) as a primary or secondary imaging method. The use of 4D ICE offers a non-invasive and potentially more detailed visualization of the heart's structures, which could improve procedural outcomes and reduce the risk of complications. By evaluating these imaging techniques, researchers hope to discover more effective ways to guide heart procedures, ultimately leading to better patient care.
What evidence suggests that this trial's imaging techniques could be effective for atrial fibrillation?
This trial compares two imaging guidance methods for heart procedures related to atrial fibrillation. Research has shown that 4D Intracardiac Echocardiography (ICE), used as the primary imaging guidance in Arm 2, effectively guides heart procedures. It provides live images of the heart, aiding doctors in performing procedures safely. Early clinical experience demonstrated that 4D ICE is both safe and helpful for these interventions.
Participants in Arm 1 will receive Transesophageal Echocardiography (TEE) as the primary imaging guidance. TEE has a long history of success and effectively prevents strokes in patients with certain heart conditions, such as atrial fibrillation. Although more invasive than ICE, TEE remains a trusted and reliable method for heart imaging and guiding procedures. Both imaging techniques are valuable for guiding heart procedures and ensuring successful outcomes.12467Who Is on the Research Team?
Dhanunjaya Lakkireddy
Principal Investigator
Kansas City Heart Rhythm Institute
Are You a Good Fit for This Trial?
This trial is for men and women aged 18-80 with a history of atrial fibrillation or flutter who are scheduled for a procedure to close off a part of the heart called the left atrial appendage using specific devices. It's not for those with blood clots in that area, pregnant individuals, patients with complex heart anatomy, or those unwilling to consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intraprocedural Guidance
Participants undergo left atrial appendage closure (LAAC) with either TEE or 4D ICE as primary imaging guidance
Post Procedural Follow-up
Participants are monitored for post-procedural outcomes such as leaks, device-related thrombus, and procedural success
What Are the Treatments Tested in This Trial?
Interventions
- Imaging guidance with TEE and ICE
- Left atrial appendage closure
Left atrial appendage closure is already approved in European Union, United States for the following indications:
- Prevention of cardio-embolic stroke in patients with atrial fibrillation at high bleeding risk
- Prevention of cardio-embolic stroke in patients with atrial fibrillation at high bleeding risk
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kansas City Heart Rhythm Research Foundation
Lead Sponsor